HeartSciences Inc. (HSCS) Share-based Compensation (2021 - 2026)

HeartSciences (HSCS) has reported Share-based Compensation for 6 consecutive years, with $324841.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Share-based Compensation rose 238.57% year-over-year to $324841.0; the trailing twelve-month figure through Apr 2026 stood at $544732.0 (up 147.73% YoY), and the FY2026 full-year result was $1.3 million, up 228.1% from the prior year.
• Share-based Compensation eased to $324841.0 in Q2 2026 per HSCS's latest filing, from $1.5 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $1.7 million in Q4 2022 and bottomed at -$49853.0 in Q2 2022.
• Historically, Share-based Compensation has averaged $940904.9 across 5 years, with a median of $1.3 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Share-based Compensation soared 210172.28% in 2022, then slumped 94.89% in 2024.
• Over 5 years, Share-based Compensation stood at $1.7 million in 2022, then declined by 5.83% to $1.6 million in 2023, then fell by 6.25% to $1.5 million in 2024, then changed by 0.0% to $1.5 million in 2025, then slumped by 78.34% to $324841.0 in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $324841.0, $1.5 million, and $777400.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.